Insulin, Isophane: all 33 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- RCT Glargine vs NPH for Treatment of DM in PregnancyRecruitingNCT06619301Phase 3
- Use of NPH Versus Basal Bolus Insulin for Steroid Induced HyperglycemiaTerminatedNCT03511521Phase 4Results posted
- Insulin Schemes for Type 2 Diabetes ControlCompletedNCT03350984Phase 4Results posted
- A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal InsulinTerminatedNCT02131272Phase 3Results posted
- Inpatient Diabetes on CorticosteroidsCompletedNCT01970241Phase 4Results posted
- Comparison of Insulin Therapy in Treating Post-Transplant DiabetesTerminatedNCT01963728Phase 4Results posted
- The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized PatientsCompletedNCT01810952Phase 4Results posted
- Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPHTerminatedNCT00564018Not applicableResults posted
- Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 DiabetesCompletedNCT00435019Phase 3Results posted
- Pre-emptive Insulin to Prevent High Glucose After a Knee Steroid Injection in Adults With Type 2 DiabetesActive, not recruitingNCT07757464Phase 1/2
- Intermediate and Long Acting Insulin Young Children Type 1 Diabetes.Status unknownNCT04664764Phase 4
- Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp MethodCompletedNCT04501250Not applicable
- Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2DCompletedNCT02607410Phase 4
- The Inova Type 2 Diabetes Mellitus StudyWithdrawnNCT02222623Not applicable
- Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology PatientsCompletedNCT02012465Early Phase 1
- Cost Effectiveness of Glargine Insulin Versus NPH InsulinCompletedNCT01832935Phase 4
- Bioequivalence of Two Insulatard® Formulations in Healthy SubjectsCompletedNCT01486901Phase 1
- Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP AxisCompletedNCT01461616Phase 3
- Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM DiagnosisStatus unknownNCT01271517Phase 4
- Treatment of Latent Autoimmune Diabetes of the AdultCompletedNCT01140438Not applicable
- Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With MetforminCompletedNCT00941148Phase 4
- Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 DiabetesTerminatedNCT00799448Phase 4
- Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 DiabetesCompletedNCT00617565Phase 3
- Safety of Insulin Detemir in Children With Type 1 DiabetesCompletedNCT00605137Phase 3
- Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 DiabetesCompletedNCT00604396Phase 3
- Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy AloneCompletedNCT00604253Phase 3
- Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 DiabetesCompletedNCT00600626Phase 3
- Human Insulin NPH and Insulin Aspart in Type 1 DiabetesCompletedNCT00597233Phase 4
- Efficacy and Safety of Insulin Detemir in Type 1 DiabetesCompletedNCT00595374Phase 3
- Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 DiabetesCompletedNCT00504673Phase 3
- Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin AspartCompletedNCT00494988Phase 4
- A Study for Patients With Type 2 Diabetes MellitusCompletedNCT00490854Phase 2/3
- Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.CompletedNCT00476437Phase 3